Exclusive

Publication

Byline

Location

US Patent Issued to Hadasit Medical Research Services & Development, Yissum Research Development Company of the Hebrew University of Jersusalem on Sept. 29 for "Methods and compositions for preventing skin toxicities caused by biological targeted cancer drugs" (Israeli Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,219, issued on Sept. 29, was assigned to Hadasit Medical Research Services & Development Ltd. (Jerusalem) and Yissum Research Development C... Read More


US Patent Issued to INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY on Sept. 29 for "Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease" (South Korean, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,220, issued on Sept. 29, was assigned to INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (Seoul, South Korea). "Pharmaceutical... Read More


US Patent Issued to Ascentage Pharma (Suzhou), Ascentage Pharma Group on Sept. 29 for "Combinations of Bcl-2/Bcl-xL inhibitors and related uses" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,221, issued on Sept. 29, was assigned to Ascentage Pharma (Suzhou) Co. Ltd. (Suzhou, China) and Ascentage Pharma Group Corp Ltd. (Hong Kong... Read More


US Patent Issued to Foundry Therapeutics on Sept. 29 for "Implantable depots for localized, sustained, controlled release of therapeutic agents to treat cancer and related conditions" (Singaporean, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,222, issued on Sept. 29, was assigned to Foundry Therapeutics Inc. (Menlo Park, Calif.). "Implantable depots for localized, sustained, con... Read More


US Patent Issued to APRECIA PHARMACEUTICALS on Sept. 29 for "Rapid disperse dosage form" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,223, issued on Sept. 29, was assigned to APRECIA PHARMACEUTICALS LLC (Mason, Ohio). "Rapid disperse dosage form" was invented by Jules Jac... Read More


US Patent Issued to ETH ZURICH on Sept. 29 for "Compounds for treating CNS- and neurodegenerative diseases" (Swiss, German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,224, issued on Sept. 29, was assigned to ETH ZURICH (Zurich). "Compounds for treating CNS- and neurodegenerative diseases" was invented by... Read More


US Patent Issued to PLEIOGENIX on Sept. 29 for "Methods of treating fibrotic liver diseases or conditions with indeglitazar" (Missouri, California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,225, issued on Sept. 29, was assigned to PLEIOGENIX INC. (Carlsbad, Calif.). "Methods of treating fibrotic liver diseases or conditions wi... Read More


US Patent Issued to Anbogen Therapeutics on Sept. 29 for "Pharmaceutical kits and uses thereof for treating colorectal cancer" (Taiwanese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,226, issued on Sept. 29, was assigned to Anbogen Therapeutics Inc. (Taipei City, Taiwan). "Pharmaceutical kits and uses thereof for treati... Read More


US Patent Issued to Board of Regents, The University of Texas System on Sept. 29 for "Tubulin polymerization inhibitor for cancer therapy" (Texas Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,228, issued on Sept. 29, was assigned to Board of Regents, The University of Texas System (Austin, Texas). "Tubulin polymerization inhibit... Read More


US Patent Issued to INVENTISBIO on Sept. 29 for "Oral formulations and uses thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,229, issued on Sept. 29, was assigned to INVENTISBIO Co. LTD. (Shanghai). "Oral formulations and uses thereof" was invented by Xing Dai (S... Read More